Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, NY, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa" or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies...
-
New York, NY, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
Manhattan, NY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) (“Healixa,” “EMOR” or the “Company”), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, NY, July 28, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, New York, June 14, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
New York, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive...
-
Manhattan, NY & Las Vegas, NV, March 16, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative...